Chen et al. revealed also that circFNTA can promote the expression of FNTA by competing with microRNA miR-370-3p, thereby activating KRAS signaling, promoting the invasion and cisplatin resistance of bladder cancer cell [48]. The gene discussed is KRAS; the disease is urinary bladder cancer.